Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04204018 · ClinicalTrials.gov registry record · NA

Measuring Practice Pattern Changes and Clinical Utility of a Novel Test for Preeclampsia

A NA study, sponsored by Qure Healthcare.

Completed
Registry status
NA
Development phase
108
Enrollment target

NCT04204018 is a NA study that has completed, run by Qure Healthcare. The registered enrollment target is 108 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04204018, a NA study, has completed, sponsored by Qure Healthcare.

COMPLETED
Registry status
NA
Development phase
108 participants
Enrollment target

Study Summary

This study will collect high-quality data on how practicing obstetricians across the U.S. currently manage patients showing signs and/or symptoms of preeclampsia and how the results of Progenity's test change clinical decision making. To do so, this study leverages simulated patient cases called Clinical Performance and Value vignettes (CPVs) in a proven methodology to rapidly measure physician care decisions.

Interventions

  • OTHER Experimental Arm

Trial Details

FieldValue
Enrollment Target 108 participants
Start Date 2019-11-22
Est. Completion 2019-12-23
Phase NA

Sponsor

Qure Healthcare

21 total trials

What the Registry Record Tells You About NCT04204018

The ClinicalTrials.gov registry entry for NCT04204018 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Qure Healthcare, which has 21 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Experimental Arm is the first listed.

NCT04204018 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04204018 about?

NCT04204018 is a clinical study titled "Measuring Practice Pattern Changes and Clinical Utility of a Novel Test for Preeclampsia". This study will collect high-quality data on how practicing obstetricians across the U.S. currently manage patients showing signs and/or symptoms of preeclampsia and how the results of Progenity's test change clinical decision making. To do so, this study leverages simulated patient cases called Cli...

What is the current status of trial NCT04204018?

This trial is currently completed. It is a NA study. The enrollment target is 108 participants. The study started on 2019-11-22. Estimated completion is 2019-12-23.

What interventions are being tested in trial NCT04204018?

The interventions under investigation include: Experimental Arm (OTHER).

Who is sponsoring clinical trial NCT04204018?

This trial is sponsored by Qure Healthcare, which has 21 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.